Executive Summary
The role of the Medical Science Liaison is changing.
MSLs have traditionally served as scientific bridges between pharmaceutical companies and external healthcare professionals, providing non-promotional scientific information, gathering field insights, and supporting evidence-based discussions around therapies and disease areas.
That role remains important, but the environment surrounding it is becoming more complex.
Healthcare professionals have greater access to scientific information, while emerging therapies increasingly require sophisticated discussions involving biomarkers, real-world evidence, treatment pathways, and complex mechanisms of action. At the same time, digital engagement and artificial intelligence are changing how scientific information is accessed and analyzed.
The future MSL will therefore need to do more than communicate scientific knowledge.
MSLs will increasingly operate as strategic intelligence professionals who combine scientific expertise, digital capabilities, data interpretation, and relationship management. Their value will come not simply from delivering information, but from helping organizations understand what clinicians, researchers, and healthcare systems are experiencing in the real world.
For life sciences companies, this evolution could make the MSL function an increasingly important source of scientific insight and organizational intelligence.
Why Is the MSL Role Changing?
The scientific environment has become significantly more complex.
New modalities, precision therapies, advanced diagnostics, biomarkers, and increasingly specialized treatment approaches require deeper scientific conversations between pharmaceutical companies and external experts.
At the same time, healthcare professionals can access clinical literature, guidelines, conference content, and scientific information through digital channels without relying exclusively on pharmaceutical representatives.
This changes the MSL’s value proposition.
The future MSL must provide context rather than simply information. The ability to interpret emerging evidence, understand clinical challenges, and engage experts in meaningful scientific dialogue will become increasingly important.
How Is Digital Engagement Changing MSL Activities?
Face-to-face interaction will remain important, but it is becoming one component of a broader engagement model.
Virtual meetings, digital scientific platforms, webinars, email, and other channels allow MSLs to maintain relationships across wider geographic areas and interact with experts more frequently.
Digital engagement also creates opportunities for more targeted interactions.
An MSL could use information about an expert’s research interests or previous scientific discussions to prepare a more relevant conversation rather than relying on standardized engagement.
However, digital does not automatically mean better.
Scientific engagement still depends on credibility, relevance, and trust. The strongest future model will likely combine personal relationships with digital convenience rather than replace human interaction entirely.
What Will AI Mean for Medical Science Liaisons?
AI could become one of the most important technologies shaping the MSL function.
AI tools can help MSLs search scientific literature, summarize emerging evidence, identify relevant publications, prepare for expert discussions, and organize large volumes of information.
AI may also help identify patterns across field insights.
For example, multiple MSL interactions may reveal recurring questions about a treatment, emerging evidence gaps, or challenges physicians are encountering in clinical practice. AI could help aggregate these signals and identify themes that would be difficult to detect manually.
The MSL’s role would then shift further from information delivery toward interpretation and strategic insight.
Human judgment will remain critical, particularly when scientific evidence is ambiguous or when AI-generated outputs require validation.
Could MSLs Become Strategic Intelligence Sources?
This may be one of the most important changes.
MSLs interact directly with researchers, clinicians, investigators, and other scientific stakeholders. These conversations can provide insights that are difficult to obtain from published literature alone.
Field teams may hear about:
- Emerging clinical practice patterns
- Unmet patient needs
- Evidence gaps
- Investigator priorities
- Treatment challenges
- Reactions to emerging scientific data
When systematically captured and analyzed, these insights can inform medical strategy, evidence generation, clinical development, and research priorities.
The future MSL organization could therefore function as a real-world scientific sensing network.
How Will Real-World Evidence Change MSL Conversations?
The growing importance of real-world evidence will expand the scope of scientific discussions.
MSLs may increasingly engage healthcare professionals around observational studies, registries, patient outcomes, treatment patterns, and evidence generated outside randomized clinical trials.
This requires MSLs to understand not only clinical science but also the strengths and limitations of different evidence types.
Being able to explain how real-world findings complement clinical trial evidence will become increasingly valuable as pharmaceutical companies seek a more complete understanding of how therapies perform in practice.
Will MSLs Need New Skills?
Scientific expertise will remain the foundation of the role, but the skills required around that expertise will broaden.
Future MSLs will increasingly need capabilities in:
- Data interpretation and scientific analytics
- Digital engagement
- Real-world evidence
- AI-assisted research
- Strategic communication
- Cross-functional collaboration
They will also need stronger understanding of how scientific insights move through the organization.
An MSL who can identify an important field signal is valuable. An MSL who can explain why that signal matters for evidence generation, clinical development, or medical strategy can create substantially greater organizational value.
How Will MSLs Work With Medical Affairs?
The future MSL is likely to become more deeply integrated into the broader Medical Affairs organization.
Rather than operating primarily as an external engagement function, MSL teams could increasingly contribute to evidence planning, scientific strategy, insight generation, and launch preparation.
This requires stronger feedback loops between field teams and headquarters.
Field insights should not disappear into disconnected reports. They should be captured in structured systems, analyzed systematically, and connected to decisions.
Technology can support this process, but organizational design will be equally important.
Will Human Relationships Still Matter?
Yes.
The increasing availability of digital information does not eliminate the importance of trusted scientific relationships.
Healthcare professionals may have access to thousands of scientific sources, but they still need credible experts who can discuss evidence, challenge assumptions, and provide context.
MSLs occupy a distinctive position because their role is centered on scientific exchange rather than traditional commercial promotion.
As AI generates more information, trusted human interpretation could become even more valuable.
The future MSL will therefore be neither purely digital nor purely relationship-driven. The role will combine scientific credibility, technology, and human judgment.
What Are the Biggest Challenges?
The transformation of the MSL role also creates challenges.
AI-generated scientific information must be carefully reviewed to avoid inaccuracies. Digital engagement requires appropriate privacy and compliance controls. Field insights must be captured consistently without compromising the quality or independence of scientific interactions.
Organizations must also avoid turning MSLs into data-collection functions.
The value of field engagement comes from scientific understanding and meaningful relationships. Excessive measurement or administrative requirements could reduce the time available for those activities.
Pharmaceutical companies will therefore need to balance technology-enabled productivity with the human elements that make the MSL function effective.
How Should Pharma Companies Prepare?
Companies should treat the evolution of MSLs as a capability transformation rather than simply a technology project.
Medical Affairs leaders should define what the future MSL is expected to contribute and then align recruitment, training, technology, and performance measures accordingly.
Three priorities are particularly important:
- Build stronger digital and data capabilities across MSL teams.
- Integrate field insights into broader Medical Affairs intelligence systems.
- Train MSLs to use AI responsibly while maintaining scientific and compliance oversight.
Performance measurement should also evolve. Activity metrics such as the number of interactions may become less meaningful than the quality of scientific engagement and the organizational value of insights generated.
What Will the MSL Role Look Like in the Future?
The future MSL may operate at the intersection of science, technology, and strategy.
Before engaging an expert, an MSL could use AI-assisted tools to understand the latest research and identify relevant evidence. During the interaction, the MSL could focus on nuanced scientific discussion and understanding the expert’s perspective. Afterward, digital systems could help structure and connect the resulting insights with broader organizational knowledge.
This creates a continuous intelligence loop:
Scientific evidence → Expert engagement → Field insight → AI-assisted analysis → Medical strategy → New evidence
As this model develops, MSL teams could become increasingly important contributors to organizational learning.
Conclusion
The future of Medical Science Liaisons will be defined by evolution rather than replacement.
Scientific expertise and trusted relationships will remain the foundation of the role, but MSLs will increasingly need to operate across digital engagement, real-world evidence, data interpretation, and AI-enabled workflows.
The most valuable MSLs will not simply know the science. They will understand how scientific evidence is evolving, what clinicians and researchers need, and how those insights can inform better decisions across the pharmaceutical organization.
For Medical Affairs leaders, the opportunity is significant.
By combining human scientific judgment with digital intelligence, pharmaceutical companies can transform the MSL function from a primarily field-based engagement capability into a strategic source of scientific insight.
The future MSL will not be replaced by technology. The role will be amplified by it.
Medical Science Liaisons Are Entering a New Era
Medical Science Liaisons (MSLs) are becoming increasingly important in the modern healthcare and pharmaceutical industries. As scientific knowledge continues to expand, Medical Science professionals are helping connect healthcare experts, researchers, and life sciences companies through meaningful scientific discussions.
The role of Medical Science Liaisons is also changing as digital communication, real-world evidence, and advanced data analytics become more widely used. MSLs can now engage with healthcare professionals through virtual meetings, online educational platforms, and data-driven scientific exchanges.
Technology Is Transforming Medical Science
Technology is expected to play a major role in the future of Medical Science. Artificial intelligence, real-world data, and digital health platforms can help MSL teams identify important scientific insights and communicate complex information more efficiently.
Rather than simply sharing product information, modern Medical Science teams increasingly focus on scientific exchange, evidence generation, and understanding the needs of healthcare professionals and patients.
The Growing Strategic Role of MSLs
The future of Medical Science Liaisons will likely involve stronger collaboration across research, clinical development, medical affairs, and healthcare organizations. MSLs can contribute valuable insights from interactions with experts and help organizations understand emerging trends in clinical practice.
As pharmaceutical innovation continues to accelerate, Medical Science Liaisons are positioned to become an even more strategic part of the healthcare ecosystem. Their ability to combine scientific expertise with communication and technology skills will remain important for the future of Medical Science.
